2BInformed: How TSCA Amendments Impact Industries and Managing the EPA’s Risk Evaluations
Podcast - Developments in FDA & DOJ Regulation and Enforcement of Manufacturer Communications
Newly Amended Dual Agency Disclosure Law: Much Ado About Nothing
In 2019, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. We review top developments below: 1) PMPRB: Amendments to Regulations will come into force July 1, 2020, court...more
Below are the major highlights in Canadian life sciences intellectual property and regulatory law that we have reported on in the first half of 2019....more